Price basics
What changes the monthly cost of tirzepatide?
The biggest cost driver is the access path. Branded Zepbound is labeled for chronic weight management and certain obstructive sleep apnea use in adults with obesity; Mounjaro is labeled for type 2 diabetes. Coverage, deductibles, prior authorization, savings cards, pharmacy availability, and cash-pay policies can change the final price. Compounded tirzepatide is different: it is prepared for an individual prescription and should not be described as an FDA-approved finished drug.
- Peptide12 lists compounded tirzepatide at $529 monthly, $429 per month on a 3-month plan, and $329 per month on a 6-month plan when a clinician determines it is appropriate.
- Branded tirzepatide cost depends heavily on insurance benefits, diagnosis, prior authorization, manufacturer programs, and which pharmacy dispenses the prescription.
- A low advertised price is not enough if it excludes clinician review, supplies, shipping, follow-up, refill handling, or clear pharmacy information.